GlassScriptPhysician profile
Alfred E Gendy
NPI 1700062346
$763.45
in general payments reported to CMS, 2019-2025
16 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.85 · 2021: $81.65 · 2022: $330 · 2023: $27.57 · 2024: $33.09 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $327.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $204.59 | 2022-2025 | |
| Abbvie INC. | $137.27 | 2022 | |
| Organon LLC | $70.00 | 2021-2024 | |
| Meditrina | $58.96 | 2025 | |
| Myovant Sciences INC. | $44.14 | 2021 | |
| Novo Nordisk INC | $31.83 | 2025 | Ozempic |
| Abbott Laboratories | $27.57 | 2023 | Freestyle Libre 2 |
| Astellas Pharma US INC | $25.06 | 2025 | Veozah |
| Exact Sciences Corporation | $23.98 | 2025 | Cologuard Collection Kit |
| Allergan, INC. | $23.85 | 2019 | |
| Pfizer INC. | $21.83 | 2024 | |
| Aspira Women'S Health INC | $20.80 | 2022 | |
| Viiv Healthcare Company | $20.43 | 2022 | |
| Sage Therapeutics, LLC | $17.93 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $17.80 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $17.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfred Gendy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.